JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 34 No. 3 405-411
© 1993 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moore, R. B.
Right arrow Articles by McPhee, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moore, R. B.
Right arrow Articles by McPhee, M. S.

Measurement of PDT-Induced Hypoxia in Dunning Prostate Tumors by Iodine-123-Iodoazomycin Arabinoside

Ronald B. Moore, J. Donald Chapman, John R. Mercer, Rezaul H. Mannan, Leonard I. Wiebe, Alexander J. McEwan and Malcolm S. McPhee

Departments of Radiation Oncology, Nuclear Medicine and Surgery, Cross Cancer Institute, Edmonton, Alberta, Canada
Departments of Radiology and Diagnostic Imaging and Surgery and Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada

Correspondence: For correspondence or reprints contact: J. Donald Chapman, Tumor Biology and Biophysics, Fox Chase Cancer Center, 7701 Burholme Ave., Philadelphia, PA 19111.

ABSTRACT

Photodynamic therapy (PDT) is known to produce vascular damage in solid tumors resulting in secondary ischemia and tumor cell death from hypoxia. The oxygenation status of both non-treated and PDT-treated Dunning R3327-AT prostate tumors growing in Fischer X Copenhagen rats was investigated with the novel hypoxic marker, 123I-iodoazomycin arabinoside (IAZA). Both qualitative and quantitative data from planar scintigraphy of anesthetized tumor-bearing rats showed increased retention of 123>I-IAZA in tumors treated with PDT. Tumor perfusion in the same tumors was measured with 99mTc-hexamethylpropyleneamineoxime (HMPAO). Region of interest analyses revealed an inverse correlation between tumor hypoxia measured by 123I-IAZA and tumor perfusion as measured by 99mTc-HMPAO (coefficient of correlation, r = –0.72). Planar images of 2-mm frozen sections from a large tumor showed 123I-IAZA selectively retained in the region that had been treated with PDT. This and other iodinated azomycin nucleosides, labeled with 123I, show promise for monitoring tumor oxygenation status noninvasively and, in particular, for monitoring the effectiveness of interstitial PDT treatments where perfusion shutdown is a major mechanism of tumor response.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
Z. Xiao, S. Halls, D. Dickey, J. Tulip, and R. B. Moore
Fractionated versus Standard Continuous Light Delivery in Interstitial Photodynamic Therapy of Dunning Prostate Carcinomas
Clin. Cancer Res., December 15, 2007; 13(24): 7496 - 7505.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. Chen, B. W. Pogue, X. Zhou, J. A. O'Hara, N. Solban, E. Demidenko, P. J. Hoopes, and T. Hasan
Effect of Tumor Host Microenvironment on Photodynamic Therapy in a Rat Prostate Tumor Model
Clin. Cancer Res., January 15, 2005; 11(2): 720 - 727.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H.-W. Wang, M. E. Putt, M. J. Emanuele, D. B. Shin, E. Glatstein, A. G. Yodh, and T. M. Busch
Treatment-Induced Changes in Tumor Oxygenation Predict Photodynamic Therapy Outcome
Cancer Res., October 15, 2004; 64(20): 7553 - 7561.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
S. H. Britz-Cunningham and S. J. Adelstein
Molecular Targeting with Radionuclides: State of the Science
J. Nucl. Med., December 1, 2003; 44(12): 1945 - 1961.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
R. V. Iyer, P. T. Haynes, R. F. Schneider, B. Movsas, and J. D. Chapman
Marking Hypoxia in Rat Prostate Carcinomas with {beta}-D-[125I]Azomycin Galactopyranoside and [99mTc]HL-91: Correlation with Microelectrode Measurements
J. Nucl. Med., February 1, 2001; 42(2): 337 - 344.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
T. M. Busch, S. M. Hahn, S. M. Evans, and C. J. Koch
Depletion of Tumor Oxygenation during Photodynamic Therapy: Detection by the Hypoxia Marker EF3 [2-(2-Nitroimidazol-1[H]-yl)-N-(3,3,3-trifluoropropyl)acetamide]
Cancer Res., May 1, 2000; 60(10): 2636 - 2642.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1993 by the Society of Nuclear Medicine.